Market Overview

Benzinga's Volume Movers

Share:
Related ECYT
Why Endocyte Could Be Positioned For A Surge
Benzinga's Top Downgrades
Biotech Weekly: Top Value Biotech Picks For 2015 (Seeking Alpha)
Related MRK
Fast Money Halftime Report Final Trade From January 27
White House Budget To Support Biotech Rally
Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog (Zacks)

Endocyte (NASDAQ: ECYT) shares moved up 98.63% to $29.08. The volume of Endocyte shares traded was 4678% higher than normal. Merck & Co (NYSE: MRK) and Endocyte announced the European CHMP positive opinions for VYNFINIT and the companion agents FOLCEPRI and NEOCEPRI.

LIN Media LLC (NYSE: LIN) shares rose 23.36% to $26.51. The volume of LIN Media shares traded was 718% higher than normal. Media General (NYSE: MEG) announced its plans to buy Lin Media LLC for $1.6 billion.

ANN (NYSE: ANN) shares climbed 13.70% to $42.33. The volume of ANN shares traded was 317% higher than normal. Golden Gate Capital disclosed a 9.5% stake in the company.

United Technologies (NYSE: UTX) surged 1.64% to $115.64. The volume of United Technologies shares traded was 280% higher than normal. Goldman Sachs upgraded United Tech from Neutral to Buy and raised the price target from $123.00 to $138.00.

Posted-In: volume moversNews Intraday Update Markets Movers

 

Related Articles (ANN + ECYT)

Around the Web, We're Loving...

Get Benzinga's Newsletters